Mass General Brigham Ventures
Corporate VCBoston · Seed–Series A · 9 people tracked
Find your way into Mass General Brigham Ventures
2,744 people in our graph share verified history with the Mass General Brigham Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Through its Artificial Intelligence and Digital Innovation Fund, Mass General Brigham Ventures backs venture-stage companies whose products and services advance the health system's strategic priorities, with a focus on artificial intelligence and digital innovation in healthcare.
Source: firm website, verified Aug 11, 2026.
Team · 9 people
from curated & public directories
What they invest in
from 3 of 3 portfolio companiesBiotech ×2Healthtech ×2AI & Machine Learning ×1Digital Health ×1
HQs:United States×3
Investments · 3 tracked
founders shown can be your intro pathBy year:2025 · 12020 · 12 dated
Abcuro develops therapies that target highly cytotoxic T cells for autoimmune diseases, including its lead candidate ulviprubart for inclusion body myositis.
BiotechHealthtechNewton, US
Steven A. Greenberg(Chief Scientific Advisor & Co-Founder)Steven A. Greenberg, MD(Chief Scientific Advisor & Co-Founder)John Alexander Martin(Executive Officer, Director)Stefano Gulla(Executive Officer)Evan Thompson(Executive Officer)David de Graaf(Executive Officer, Director)
Co-investorsBain Capital Life SciencesNew Enterprise Associates (NEA)RA CapitalSamsara BioCapitalSanofi VenturesREDMILE+8 more
CodaMetrix operates an AI-based contextual coding automation platform that converts clinical data and chargeable activities into billable, clinical, and demographic medical codes for hospitals and health systems.
AI & Machine LearningDigital HealthHealthtechBoston, US
Hamid Tabatabaie(Director, Executive Officer, Promoter)inMark Pottle(Executive Officer)inJim Whelan(Mr. Whelan is the Chief Revenue Officer of the Issuer.)inKevin Schmitt(Mr. Schmitt is the Chief Engineering Officer of the Issuer.)inJay Aslam(Mr. Aslam is the Chief Data Science Officer of the Issuer.)Tara Bradley(Executive Officer)
Board seatRoger Kitterman· per SEC Form D · $15M raise · filed May 2025
Co-investorsCU Healthcare Innovation FundFrist Cressey VenturesMartin VenturesSignalFireTRANSFORMATION CAPITAL
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companies
Abcuro · clinicaltrialsarena.com · Aug 19, 2026
Frequently asked questions
- What stage does Mass General Brigham Ventures invest at?
- Mass General Brigham Ventures invests at the Seed, Series A stages.
- What sectors does Mass General Brigham Ventures focus on?
- Mass General Brigham Ventures focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Mass General Brigham Ventures located?
- Mass General Brigham Ventures is headquartered in Boston, US.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.